Software company DocuSign (DOCU) scored a rating upgrade from Hold to Buy from William Blair, thanks to the optimism about ...
William Blair analyst Louie DiPalma maintained a Hold rating on Science Applications (SAIC – Research Report) today. The company’s shares ...
Equities research analysts at William Blair issued their Q1 2026 earnings estimates for shares of Sprinklr in a note issued ...
Butterfly Network exceeded Q4 estimates with 35% revenue growth. William Blair sees strong upside, citing homecare potential ...
Equities research analysts at William Blair cut their Q4 2026 earnings estimates for shares of Duluth in a research report issued to clients and investors on Thursday, March 13th. William Blair ...
We recently published a list of 11 Best Reddit Stocks to Invest In. In this article, we are going to take a look at where ...
The biopharmaceutical company announces positive results from two skin disease treatment studies. But Wall Street doesn’t ...
Investor's Business Daily on MSN1h
Incyte Loses 9% As Skin Disease Drug Looks 'Viable, But Not Competitive'Incyte's skin disease treatment looks "viable, but not competitive with biologics," an analyst said Monday as Incyte stock fell.
A Greenville County judge struck “Ponzi scheme” from an investor lawsuit alleging the Camperdown project was part of a fraud scheme by WCM Global Wealth LLC.
A Wall Street analyst believes Palantir's (NASDAQ: PLTR) expanding artificial intelligence (AI) ecosystem, marked by major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback